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Abstract
Background: Developmental angiogenesis proceeds through multiple morphogenetic events including sprouting,
intussusception, and pruning. Mice lacking the membrane-anchored metalloproteinase regulator Reck die in utero
around embryonic day 10.5 with halted vascular development; however, the mechanisms by which this phenotype
arises remain unclear.
Results: We found that Reck is abundantly expressed in the cells associated with blood vessels undergoing
angiogenesis or remodelling in the uteri of pregnant female mice. Some of the Reck-positive vessels show
morphological features consistent with non-sprouting angiogenesis. Treatment with a vector expressing a small
hairpin RNA against Reck severely disrupts the formation of blood vessels with a compact, round lumen. Similar
defects were found in the vasculature of Reck-deficient or Reck conditional knockout embryos.
Conclusions: Our findings implicate Reck in vascular remodeling, possibly through non-sprouting angiogenesis, in
both maternal and embyornic tissues.
Background
Developmental angiogenesis proceeds through multiple
morphogenetic events including sprouting, intussuscep-
tion (splitting of pre-existing vessels by tissue pillars),
and pruning [1-3]. Several key molecules in sprouting
angiogenesis have been identified: e.g., vascular endothe-
lial growth factor (VEGF) family members and their
receptors, Notch and its ligand Delta-like ligand 4
(Dll4), and semaphorins and their receptors plexin/neu-
ropilin complexes [4-6]. Little is known, however, about
the molecular bases of intussusception and pruning.
The uteri of pregnant mice are among the most active
sites of physiological angiogenesis in adult mice. Around
7 days post-coitum (7 dpc; the day when the copulation
plug was confirmed is considered as 0.5 dpc in this
study), the implantation chambers around the embryos
are established as several swellings along the uterine
horns, and in these swellings, active and precisely con-
trolled tissue remodeling, termed decidualization, takes
place [7-9]. The remodeling is particularly active in the
area closer to the broad ligament (i.e., mesometrial pole)
where the placenta will eventually form. In terms of his-
tology, two distinct compartments of decidua, which we
term in this paper “area of sinus formation” (AS) and
“decidua basalis” (DB), respectively, become evident by 7
dpc (Figure 1A). Concomitant with the remodeling,
decidual tissue acquires a complex network of newly
formed vasculature that undergoes constant modifica-
tion to meet the demands of the growing embryo [10].
Previous studies have implicated various growth factors
(e.g., VEGF, basic fibroblast growth factor), extracellular
matrix (ECM) components, and matrix metalloprotei-
nases (MMPs) in the regulation of decidual remodeling
[11]. In particular, Mmp2 and Mmp9 show dynamic
expression patterns in the implantation chamber and
are required for proper decidual remodeling; endogen-
ous MMP inhibitors, such as TIMP-3, have also been
implicated in the regulation of decidual remodeling
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reproduction in any medium, provided the original work is properly cited.Figure 1 Reck-immunoreactivity associated with blood vessels in the mouse implantation chamber. (A) Distinct domains in the mouse
implantation chamber at around 7 dpc. (B) Reck-immunoreactivity (dark brown) in the AS and DB in a longitudinal section of a 7-dpc mouse
implantation chamber. (C) Loop-shaped structures in DB sections doubly stained for Reck (green) and an endothelial cell marker (red) [PECAM;
panel 1] or a mural cell marker (red) [SMA, desmin, or NG2; panels 2, 3, 4, respectively] followed by nuclear counter-staining with DAPI (blue
signals; panels 2-4). (D) An example of bifurcating vessels in the DB found in serial sections (4 μm-thick) stained for Reck. Red arrows indicate
protruding vessel walls (panel 1) which form a contact zone (panel 2) and eventually separate the vessel into two smaller tubes (panels 3, 4). (E)
An example of characteristic Reck-positive cells associated with the contact zone. Two adjacent sections were stained with hematoxylin-eosin
(H&E) (panel 1) and immuno-stained for Reck (panel 2), respectively. Blue arrows indicate the contact zone. (F) The wedge-shaped cells lying
across the contact zone are positive for Reck (panel 1), SMA (panel 2; fluorescent double staining with Reck), and desmin (panel 3; fluorescent
staining). Scale bar: B, 100 μm; C, E, F, 20 μm; D, 30 μm.
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are selectively preserved during this highly destructive
process is yet to be elucidated.
Reversion-inducing cysteine-rich protein with Kazal
motifs (RECK) was initially identified as a cDNA clone
inducing morphological reversion (flat reversion) in
NIH3T3 cells transformed by the v-K-ras oncogene [14].
RECK encodes a membrane-anchored metalloproteinase
regulator [14-17] that is down-regulated in many cancer
cells [18]. RECK suppresses tumor angiogenesis, inva-
sion, and metastasis when artificially expressed in tumor
cells [14,15]. Accumulating evidence indicates that
RECK is down-regulated in various solid tumors and
that the level of residual RECK expression in resected
tumors often correlates with better prognosis, support-
ing the authenticity of RECK as a clinically relevant
tumor suppressor [18]. RECK has also been implicated
in the regulation of several developmental processes,
including embryonic angiogenesis, myogenesis, chondro-
genesis, neurogenesis, and maturation of neuro-muscu-
lar junctions [15,19-22]. In particular, Reck-deficient
mice die around embryonic day 10.5 (E10.5) with their
vascular network arrested at the stage of primary capil-
lary plexus, suggesting angiogenesis rather than vasculo-
genesis is affected in these animals [15]. It is still
unclear, however, why embryonic angiogenesis fails to
proceed in the absence of Reck while tumor angiogen-
esis is suppressced by Reck. In addition, due to the mid-
gestation lethality of the global Reck-deficient mice, it is
yet to be explored how Reck functions during later
stages of embryogenesis and in adult animals.
In this study, we found abundant expression of Reck
in the cells associated with blood vessels undergoing
rapid remodeling in the mouse implantation chambers.
Our histological and experimental evidence implicates
Reck in vascular remodeling which may involve non-
sprouting mechanisms such as intussusception and
pruning.
Results
Reck is abundantly expressed in the cells associated with
remodeling blood vessels in the mouse implantation
chamber
To gain insights into the functions of Reck in adult
mice, we examined its tissue distribution by immunohis-
tochemical techniques. The most abundant Reck signals
were found in multiple cell types in the uteri of preg-
nant mice (Additional files 1, 2 and 3). In the medial
longitudinal sections of the implantation chambers at 7
dpc, Reck-immunoreactivity was associated with several
loop-shaped structures in the AS as well as DB and with
numerous solitary cells in the DB (Figure 1A, B). Most
of the loop-shaped structures consisted of an inner cell
layer positive for the vascular endothelial cell marker
PECAM (Figure 1C, panel 1) and an outer cell layer(s)
positive for mural cell markers, i.e., a-smooth muscle
actin (SMA), desmin, and NG2 (Figure 1C, panels 2-4).
Reck signals seemed to be associated with both of these
cell types (note the yellow signals in Figure 1C). RECK
expression in these two cell types could be demon-
strated by immunoblot assay using cultured human vas-
cular endothelial cells (HUVECs) and vascular smooth
muscle cells (VSMCs) (data not shown). We therefore
conclude that the Reck-positive loop-shaped structures
represent blood vessels. Most of the Reck-positive soli-
tary cells, on the other hand, were associated with capil-
lary-like structures and were positive for PECAM
(Additional file 4), suggesting that they represent a sub-
population of capillary-forming endothelial cells.
As we examined the serial sections of implantation
chambers, two types of Reck-positive vasculature were
found. In one type (Figure 1D), the vessel is banana-
shaped in one section (panel 1); its opposing walls pro-
gressively protrude in subsequent sections (panel 2); and
it eventually bifurcate into two tubes (panel 4). In criti-
cal sections, central regions of the protruding walls
apose each other to form a contact zone like a crushed
rubber tube (Figure 1E, panel 1), and a group of wedge-
shaped Reck-positive cells are lying across the contact
zone (Figure 1E, panel 2). These wedge-shaped cells are
positive for SMA and desmin (Figure 1F). We also
found some vessels bifurcating on both sides (e.g., Addi-
tional file 5A) or forming a contact zone only in the
central region along their longitudinal axes (e.g., Addi-
tional file 5B).
In the second type of Reck-positive vessel (Figure 2A),
a heavily labeled tube is found in one section (panel 1);
its lumen continuously narrows in subsequent sections
(panels 2, 3); and it eventually disappears (Figure 2A,
panel 4). Such terminal cell clusters positive for Reck
(e.g., Figure 2A, panel 2, arrow) contain both endothelial
and mural cells (Figure 2B).
Although some cells associated with the bifurcating
vessels are positive for the proliferation marker Ki67
(Figure 2C, blue arrow), the terminal cell clusters were
negative for Ki67 (Figure 2C, red arrow). These two
types of Reck-positive structures progressively increased
from 6 dpc to 8 dpc, a period of active vascular remo-
deling, in the DB (Figure 2D). These data indicate that
Reck is expressed adundantly not only in embryonic
vasculature but also in the adult vasculature undergoing
rapid remodeling.
Reck shRNA interferes with vascular remodeling in the
implantation chamber
Next, we asked whether Reck plays any active roles in
vascular remodeling in the implantation chamber. To
address this question, a method that would allow
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organ was required. We employed cationized gelatin
beads [23] that continuously release plasmid DNA into
the surrounding tissues. First, to assess the efficacy of
this technique, we injected beads pre-impregnated with
a control plasmid expressing LacZ into the mesometrial
side of the mouse implantation chamber at 5 dpc (n = 7
pregnant mice) (Figure 3A) and harvested the tissue at
10 dpc for histological examinations. LacZ signals were
found in more than 50% of the cells in the area of injec-
tion (Figure 3B). We next used a plasmid expressing a
small hairpin RNA targeting Reck (sh-1); our previous
experiments indicated that the sh-1 vector reduced the
level of Reck protein down to 10% when stably trans-
fected into cultured fibroblasts [20]. Transfer of the sh-1
plasmid resulted in some winding slits in the tissue (Fig-
ure 3C, panel 3, arrows) instead of compact round ves-
sels as found in the control (Figure 3C, panel 1) and a
marked reduction in type IV collagen-immunoreactivity
(Figure 3C, panel 4) as compared to the control (Figure
3C, panels 2). We also used another plasmid expressing
less active shRNA (sh-2), which knocks Reck down to
30% in cultured fibroblasts [20], and found milder
effects (Figure 3D). These findings suggest that a suffi-
cient level of Reck expression is required for proper vas-
cular remodeling and ECM accumulation in this system.
Vascular defects in Reck-deficient mice
These observations in maternal tissues prompted us to re-
examine the morphology of vasculature in Reck-deficient
(Reck
-/-) mouse embryos. As we previously reported [15],
these embryos die around E10.5 with dilated blood vessels
and abdominal hemorrhage (Figure 4B, panels 2, 3), while
heterozygous (Reck
+/-) littermates show no obvious devel-
opmental abnormality or infertility. When vascular base-
ment membranes in the sagittal sections of the embryos
were visualized by laminin-staining (Figure 4C), a series of
periodically spaced contact zones were found in the peri-
neural vasculature in the wild type E10.5 littermates (Fig-
ure 4C, panel 1, blue arrows). In contrast, such contact
zones were rare in the corresponding vessels of Reck-defi-
cient littermates (Figure 4C, panels 2, green arrow). In
more severe cases (Figure 4C, panels 3, 4), embryos had
tissue slits with wide (green arrows) and/or winding spaces
(red arrows), which is reminiscent of the tissue slits found
in the implantation chamber after sh-1 transfection (see
Figure 3C, panels 3, 4).
When normal yolk sac vasculature was visualized by
whole-mount Flk1-immunostaining, numerous small
holes were found in its arterial domain (Figure 4D,
panels 1, 2, blue arrows). In the Reck-deficient yolk sacs,
however, such holes were rare, and instead irregularly
shaped sprouts (or branches) were abundant (Figure 4D,
panels 3, 4, red arrows). In addition, arteries in the lat-
eral region of the normal yolk sacs looked relatively
straight and uniformly flattened (Figure 4D, panel 1),
while those in Reck-deficient yolk sacs looked winding
and variable in thickness (Figure 4D, panel 3). These
findings also support the idea that Reck is required for
proper vascular remodeling.
Figure 2 Reck-immunoreactivity associated with clusters of vascular cells in the mouse implantation chamber. (A) An example of a
cluster of cells (red arrow) positive for Reck at a vessel terminus found in the DB. (B) Immunofluorescent double staining of a terminal cell
cluster for Reck (green) and PECAM (red; panel 1) or Reck (red) and SMA (green; panel 2) followed by nuclear counter-staining with DAPI (blue).
(C) Two adjacent sections stained for Reck (panel 1) and Ki67 (panel 2), respectively. Blue arrows: a bifurcating vessel. Red arrows: a terminal cell
cluster. (D) Temporal changes in the number of Reck-positive bifurcating vessels (blue bar) and terminal cell clusters (red bar) per slice from the
medial part of implantation chambers. Bar represents mean ± s.e.m., n = 7. The difference between stages is statistically significant (p < 0.05) for
both Reck-positive bifurcating vessels and terminal cell clusters. Scale bar: A, 30 μm; B, C, 20 μm.
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Page 4 of 13Figure 3 Reck shRNA interferes with vascular remodeling in the mouse implantation chamber. (A) The site of bead injection (red line) in
the mesometrial area at 5 dpc. (B) Control experiments to assess the efficiency of gelatin-bead-mediated gene transfer into the implantation
chamber. Cationized gelatin beads impregnated with a LacZ-expression vector were injected into the mesometrial area at 5 dpc, and tissue
slices were prepared at 10 dpc and stained with X-gal. A typical image is shown. (C) Mesometrial tissue at 10 dpc that had been transfected on
5 dpc with a plasmid expressing either LacZ (panels 1, 2) or shRNA against Reck (sh-1; panels 3, 4) was sliced and stained with H&E (panels 1, 3)
or immunostained for type IV collagen (panels 2, 4). The yellow double-headed arrows indicate the DB, and the black arrows abnormal vessels.
(D) The frequency of samples with abnormal decidua after transfection with vectors expressing LacZ or either of the two shRNA against Reck,
sh-1 and sh-2, with different efficacy. Embryos were scored abnormal when the vessels in the transfected areas were severely disrupted as
shown in panels 3 and 4 in C; the abnormality was often accompanied by reduced cellularity in the areas as well. Bar represents mean ± s.e.m.,
n = 7 pregnant mice. Total implantation chambers tested: LacZ, 81; sh-1, 88; sh-2, 86. Student’s t-test: LacZ vs. sh-1, p = 1.7 × 10
-8; LacZ vs. sh-2,
p = 1.4 × 10
-5; sh-1 vs. sh-2, p = 1.6 × 10
-5. Scale bar: B, 200 μm; C, 100 μm.
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To further test this idea, we generated mice in which
Reck expression can be conditionally silenced using a
tamoxifen-inducible recombination (CAG-CreER
T2/
loxP) system [24,25] (Figure 5A). When tamoxifen-treat-
ment (i.e., Reck-inactivation) was started from E11, the
Cre-positive (i.e., Reck-inactivated) mice still showed
embryonic lethality, indicating the continued importance
of Reck during the later stages of development. These
Reck-inactivated mice (Figure 5B) were still alive at
E15.5, but by this time exhibited smaller-than-normal
body sizes, pale body colors, and severe haemorrhage
(Figure 5C). Histological examination indicated that in
contrast to the compact and finely distributed vessels in
the tissues of control animals (Figure 5D and Figure 6,
left panels), large and irregularly shaped blood vessels,
with frequently extravasated red blood cells, were found
in various tissues of the Reck-inactivated mice (Figure
5D and Figure 6, right panels). Brain vasculature in
these embryos were disorganized and interrupted by
large spaces or cavities (Figure 6A-C, right panels,
arrows), which was in sharp contrast to the fine network
in the control animals (Figure Figure 6A-C, left panels).
In the liver of control animals (Figure 6D, E, left panels),
round and compact blood vessels tightly and evenly sur-
rounded by NG2-positive cells (pericytes) were found.
In the livers of the Reck-inactivated animals (Figure 6D,
E, right panels), abnormal vessels with larger luminal
spaces and loosely associated NG2-positive cells were
found. Hence, the most obvious phenotype in these
Reck conditional knockout mice was again vascular
abnormality, albeit milder than that in the global Reck-
deficient mice.
Discussion
Our previous study indicated that Reck expression is
abundant in vascular smooth muscle cells in mouse
embryos at around E10.5 and that Reck is required for
embryonic angiogenesis rather than vasculogenesis [15].
I nt h ep r e s e n ts t u d y ,w ef o u n dt h a ta b u n d a n tR e c k
Figure 4 Vascular defects in Reck-deficient mice. (A) Schematic representation of the 5’-terminal region of the wild type (wt)a n daReck
mutant (Reck
-) allele. This mutant allele lacks exon 1 and hence no Reck protein is expressed [15]. (B) A typical E10.5 wild type embryo (panel 1)
and a Reck
-/- embryo (panel 2) which shows abdominal hemorrhage and dilated vessels (panel 3, magnified view of the area indicated by yellow
box in panel 2). The heart was beating in this typical mutant embryo. (C) The perineural area in the sagittal sections of wild type (panel 1) or
Reck
-/- (panel 2-4) embryos stained for a basement membrane-marker, laminin. The samples in panels 2-4 represent mild, intermediate, and
severe phenotypes, respectively. The blue arrows in panel 1 indicate contact zones in the wild type perineural vascular plexus, the green arrows
continuous perineural vessels (panels 2, 4), and the red arrows winding vascular spaces or tissue slits (panels 3, 4). (D) Vascular networks in E10.5
wild type (panel 1; a magnified view in panel 2) or Reck
-/- (panel 3, a magnified view in panel 4) yolk sac visualized by whole-mount
immunostaining for Flk-1. Blue arrows and red arrows indicate small holes and abnormal sprouts, respectively. Scale bar: B, 1 mm in panels 1, 2
and 200 μm in panel 3; C, 50 μm; D, 20 μm in panels 1, 3 and 10 μm in panels 2, 4.
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(Figure 1 and Additional files 123) where adult angio-
genesis is actively taking place and that abundant Reck
expression can be detected in both proliferative and
non-proliferative cells (Figure 2C; Additional files 1, 2).
We also found that reduced, or loss of, Reck expression
hinders formation of compact and organized vascular
structure and instead results in tissue slits or cavities
with frequent blood leakage both in the maternal (Fig-
ure 3C) and embryonic (Figure 4B, C; Figure 5C, D; Fig-
u r e6 )t i s s u e s .I nn o r m a ly o l ks a c s ,s m a l lh o l e si nt h e
endothelial tubes, which resemble the tissue pillars in
intussusception [1-3], are frequently found; in Reck-defi-
cient yolk sacs, the small holes decrease while sprout-
like structures increase (Figure 4D). These findings are
consistent with the model that Reck is (or Reck-positive
cells are) required for the remodeling of immature
vascular plexus into a hierarchically branched system
(Figure 7A, B).
In addition to the smooth muscle cells surrounding
the endothelial tubes (Figure 1C), the wedge-shaped
cells lying across the contact zone in bifurcating ves-
sels were positive for Reck, SMA, and desmin (Figure
1E, F). The shape and localization of these cells are
consistent with the myofibroblasts and smooth muscle
cells postulated to be involved in the tissue pillar for-
mation during intussusception [3]. The presence of
vessels forming contact zones only transiently along
their longitudinal axes (e.g., Additional file 5B) seems
to support this model. Intusussception is known to
involve less cell proliferation than sprouting and be
suited for rapid formation of hierarchically branched
structure in rapidly forming organs, such as embryonic
lung before birth [2,3]. It is therefore tempting to spec-
ulate that intussusception occurs also in the implanta-
tion chamber where intricate placental vasculature
need to be quickly generated and that Reck plays an
essential role in this process (Figure 7D). To rigorously
test this model, however, more fine 3D-reconstruction
of serial slices or vascular cast imaging by scanning
electron-microscopy is required, since occurrence of
intussusception in this organ has yet to be established
and it is hard to completely exclude other possibilities:
e.g., we are observing bifurcation points generated by
sprouting or fusion rather than splitting. Intravital
imaging of Reck-positive cells may also be useful for
testing this model.
It is now clear that Reck can be abundantly expressed
in PECAM-positive, vascular endothelial cells (Figure
1C; Additional files 2, 3, 4). Endothelial cells are hetero-
geneous in morphology, function, and gene expression
and retain high degree of plasticity [26]. For instance,
ephrin-B2 marks the endothelium of primordial arterial
vessels while its cognate receptor EphB4 marks the
Figure 5 Vascular defects in conditional Reck-deficient mice.
(A) 5’-terminal region of the conditional Reck mutant allele before
(fl) and after (Δ) CreER-mediated recombination, which leads to the
elimination of exon-2 and hence the early termination of translation.
(B) Typical genotyping data (left panel) and Reck immunoblot assay
(right panel). Reck
fl/fl females were mated with CAG-CreER;Reck
fl/-
males and treated with tamoxifen from 11 dpc; embryos were
harvested at E15.5. Yolk sac DNA was subjected to genotyping PCR
(left panels; top, Cre primers; bottom, primers flanking Reck exon-2),
while the whole embryo proteins were analyzed by immunoblot
assay (right panels; top, Reck; bottom, a-tubulin). Note the smaller
exon-2 band (lane 2, lower panel) and the absence of Reck protein
band (lane 4) in the Cre-positive mouse (lane 2, upper panel). (C)
Gross morphology of Reck
fl/fl (Cont) and Reck
Δ/- (ΔReck) embryos. The
ΔReck embryos (i.e., CAG-CreER;Reck
fl/- embryos treated with
tamoxifen; right panel) are smaller than the control (i.e., Reck
fl/fl
embryos treated with tamoxifen; left panel) and show pale body
color and haemorrhage in their heads and abdomen. The frequency
of visible haemorrhage was 0% (0/16) in control animals and 100%
(14/14) in ΔReck animals in which the hearts were beating. (D)
Sagittal sections of the control (left panels) or ΔReck embryos (right
panels) stained with H&E. Note the abnormally large blood vessels
in the back region (panel 2) and the haemorrhage in the head
region (panel 4) found in the ΔReck embryos. Scale bar: C, 1 mm; D,
100 μm.
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Page 7 of 13endothelium of primordial venous vessels [27-29].
Another example is the tip-stalk specification in sprout-
ing vessels. Vascular spouting is guided by a subset of
endothelial cells, termed tip cells, which extend filopodia
and migrate actively in response to VEGF. Tip cells are
followed by another subset of endothelial cells that form
tubular structures in response to VEGF. Delta-like 4
(Dll4) expressed in the tip cells and its receptor Notch
expressed in the stalk cells play critical role in this cell
type specification [26,30]. Variety in the components of
Figure 6 Immunohistological anayses of conditional Reck-deficient mice. Sagittal sections of the control (left panels) or ΔReck embryos
(right panels) were stained with anti-PECAM (A, B), anti-type IV collagen (C), H&E (D), or anti-NG2 (E). NG2 in the liver (E) was visualized by
immunofluorescent staining (green) followed by nuclear counter-staining with DAPI (blue). Note the abnormally large blood vessels and blood-
filled cavities (arrows) found in the head (A-C) and liver (D, E) of ΔReck embryos. Scale bar: A 200 μm; B-E, 100 μm.
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erogeneity among endothelial cells [31]. Relationships
between these different subclasses of endothelial cells
and the Reck-positive endothelial cells are interesting
issues that remain to be addressed.
What is the nature of the Reck-positive terminal cell
clusters (Figure 2A, B)? Although these structures are
located near the tips of blood vessels, they are unlikely
to represent the tip cells, since they consist of multiple
components of mature blood vessels (Figure 2B) rather
than nascent, pioneering endothelial cells. They are
more consistent with vessels undergoing regression or
pruning (Figure 7D). Occurrence of active pruning in
this organ, however, is yet to be established, and hence
this model also needs to be rigorously tested in future
studies.
What could be the machanism of action of Reck in vas-
cular remodeling? Several hypotheses can be proposed.
First, the implantation chamber is undergoing active tis-
sue remodeling, and some areas, including the AS and
DB, should be in highly destructive (or proteolytic)
micro-environment. Since Reck inhibits MMPs, it may
mark and help protect the blood vessels selected to be
preserved. Abundant type IV collagen around the Reck-
positive vessels (Additional file 6) and reduced type IV
collagen after shRNA treatment (Figure 3C, panel 4) sup-
port this model. Interestingly, the area of abandant Reck
expression roughly overlaps with the areas of Mmp2 and
TIMP-1 expression [32], implying their interplays. Sec-
ond, in light of our previous observations in other sys-
tems [19,20,33,34], Reck may be involved in more active
events such as process-extension, cell-substrate adhesion,
Figure 7 A model on the role of Reck in vascular remodeling. In the presence of Reck, an immature vascular plexus (A) can be remodeled
into a hierarchically branched system (B). Lack of Reck results in abnormally large vessels or blood-filled cavities in the tissues (C), which may
result from reduced bifurcation or excessive vascular fusion. Some of the Reck-positive cells (blue in D) may participate in vascular remodeling
via non-sprouting mechanisms, such as intussusception and pruning.
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consolidation. Third, Reck may hinder vascular fusion, by
analogy to the activity of Reck to suppress myoblast
fusion [19]. Finally, Reck may affect intracellular signaling
by protecting ECM or cell surface molecules. For
instance, Reck was previously found to enhance Notch-
signaling by inhibiting ADAM10-mediated Notch-ligand-
shedding during central nervous system development
[21]. In vascular systems, Dll4 is known to suppress tip
cell formation and vascular sprouting [26]. Reck-deficient
mouse embryos seem to have increased sprouting in
their yolk sac vasculature (Figure 4D, panels 3, 4), and
this may support the model that Reck-deficiency results
in attenuated Dll4/Notch signaling. It seems difficult,
however, to explain the tissue slits and cavities formed
after Reck knockdown/knockout solely by excessive
sprouting. The phenomena look more consistent with
the failure in non-sprouting vascular remodeling or
excessive vascular fusion (Figure 7). In any event, Reck
may shed some fresh lights on the issue of endothelial
cell heterogeneity.
We previously observed that forced expression of
RECK in fibrosarcoma results in reduced tumor vessel
branching, increased vessel diameter, and death of
tumor cells distant from expanded blood vessels [15].
Although forced expression of Dll4 in tumor cells
results in decreased tumor vessel branching and
increased vessel diameter, it promotes tumor growth
rather than cell death [35,36]. Again, it seems difficult
to fully explain the effects of RECK on tumor angiogen-
esis by enhanced Notch signaling. It is more likely that
Reck affects multiple signaling pathways (including
Notch pathway) in multiple cell types and biological
outcome of altered Reck expression reflects their net
effects.
Our recent studies suggest that Reck expression is
regulated by several external stimuli, including serum/
growth factors, cell density, and oxygen concentration
[37-39]. The present study suggests that reduced Reck
expression has devastating effects of both maternal and
embryonic tissues, which may lead to infertility, abor-
tion, and developmental defects in the offspring. Further
studies on the roles and the mechanisms of regulation
of Reck in uterine reproductive cycles and embryonic
development may provide information useful for con-
trolling these disorders.
Methods
Animals and tissues
The animal experiments were approved by Animal
Research Committee, Graduate School of Medicine,
Kyoto University and conducted following the guidelines
of Kyoto University. For immunohistochemical staining,
the mouse implantation chambers were fixed in 4%
para-formaldehyde (PFA) for 2 h (Reck, CD31, type IV
collagen, laminin, desmin, NG2, and SMA) or overnight
(Ki67). Perfusion was not used in most of the experi-
ments, for it did not make appreciable difference in ves-
sel morphology in some earlier experiments. After
fixation, paraffin embedded tissue blocks were prepared
[40] and sliced (4 μm-thick). For lacZ-staining, tissues
were fixed in 0.5% glutaraldehyde in phosphate buffered
saline without divalent cations (PBS) at 4°C for 1 h,
incubated in 30% sucrose, 2 mM MgCl2 for 30 min at
4°C, rinsed twice in PBS, embedded in OCT compound,
and stored at -80°C until the sections (10 μmt h i c k )
were prepared using a cryostat (Leica). For immuno-
fluorescence staining, tissues were fixed in 1% PFA, sub-
jected to 3 steps of buffer replacements [30 min in 0.1
Mg l y c i n ei nP B S ,3 0m i ni nH o l t ’s agarose-sucrose
(30%) solution [22], 30 min in 1:1 mixture of OCT and
Holt’s agarose-sucrose solution], embedded in OCT
compound, quickly frozen in dry ice, and sliced using a
cryostat (7 μm-thick). Unless otherwise stated, sections
were cut longitudinally near the central plane of implan-
tation chambers. For serial section analyses, at least 20
sections were prepared from a single sample.
DAB staining
To visualize Reck in tissues, paraffin sections were
stained using the monoclonal antibody 5B11D12 [14]
with the aid of the Envision+ system (Dako #K4001).
Detailed procedures and the specificity of this antibody
have been described elsewhere [15,22]. Other antibo-
dies used were as follows: type IV collagen (Progen
#10760), laminin (Progen, #10765), SMA (Dako,
M0851), PECAM (BD Pharmingen #550274), Ki67
(Nova Castra #NCL-Ki67p), and NG2/CSPG4 (Chemi-
con # AB5320). The staining of deparaffinized sections
was carried out with the aid of the Envision+ system
for SMA and following the standard ABC protocol for
PECAM, NG2, and Ki67. For PECAM staining, sec-
tions were pre-treated with Proteinase K solution
(20 μg/ml in TE Buffer, pH 8.0) for 10 min at 37°C
and allowed to cool for another 10 min at room tem-
perature (RT). For Ki67 staining, sections were heated
at 95°C in 0.01 M sodium citrate buffer for 20 min
and allowed to cool for 20 min at RT. All sections
were incubated in 3% hydrogen peroxide, 0.01%
sodium azide in PBS for 30 min to block endogenous
peroxidases, washed 3 times with PBS, blocked with
appropriate serum for 30 min, and then incubated
with primary antibodies in dilution buffer A [1% BSA
(Sigma), 0.05% sodium azide in PBS] for 1 h at RT.
Isotype-matched non-specif i cI g Gw a su s e da san e g a -
tive control. Immune-complexes were then detected
using the ABC system (Vector) with 3, 3-diaminoben-
zidine-HCl (Dako, K3467) as a chromogen.
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Sections were allowed to air-dry for 20 min at RT,
washed twice with PBS, treated with 20% BlockAce
(Dainippon Pharmaceutical, Japan) and with appropri-
ate serum (5%) in PBS overnight, and washed three
times in PBS, followed by incubation for 1 h at RT
with primary antibodies in dilution buffer B [1% BSA,
0.01% sodium azide in PBS]. The sections were then
washed three times in PBS, incubated for 1 h at RT
with secondary antibodies, washed three time in PBS,
mounted with media containing DAPI (Vector #H-
1200), and observed using a fluorescence microscope
(Axioplan, Zeiss) or a confocal laser-scanning micro-
scope (Fluoview 300, Olympus). Primary antibodies
used were the same as those used in DAB staining.
Isotype-matched non-specific IgG or pre-immune
serum was used as a control. Secondary antibodies
used are as follows: goat anti-mouse Alexa Fluor 488
(Invitrogen#A11001) for Reck and SMA, goat anti-Rat
TRITC (Jackson ImmunoResearch #112 025 167) for
PECAM, and goat anti-RabbitA l e x aF l u o r5 5 5( I n v i -
trogen#A21428) for laminin and NG2. For Reck/Des-
min double staining, rhodamine-conjugate anti-mouse
IgG (Jackson ImmunoResearch, #115-295-205) and
FITC-conjugated anti-mouse IgG2a (Jackson Immu-
noResearch, #115-095-205) were used to detect Des-
min and Reck, respectively. For Reck/SMA double
staining, a Zenon mouse IgG labeling kit (Invitro-
gen#Z25160) was employed.
LacZ staining
Sections were brought to room temperature, washed
twice with PBS, incubated overnight in X-gal solution
[0.1 M phosphate buffer (pH 7.3), 2 mM MgCl2, 0.01%
sodium deoxycholate, 0.02% NP-40, 5 mM potassium
ferricyanide, 5 mM potassium ferrocyanide, 1 mg/ml
X-Gal, 20 mM Tris-HCl (pH 7.3)], and then counter-
stained with eosin.
Plasmid delivery into implantation chambers
Cationized gelatin beads (4 mg) prepared as described
previously [23,41] were incubated in 50 μl PBS contain-
ing 40 μg plasmid DNA for 24 hr. Pregnant mice
(5 dpc) were anaesthetized by intra-peritoneal injection
of nembutal (50 mg/kg) and subjected to laporatomy to
expose each uterine horn. The bead suspension (10 μl;
~5 μg DNA) was injected into the mesometrial area of
each implantation chamber using a microsyringer. The
abdominal cavity was stitch-closed with sutures
(Akiyama, Japan). Five days after the operation, the ani-
mals were sacrificed for histological examinations. For
each plasmid DNA, seven pregnant mice (total of more
than 80 implantation sites) were used.
Mutant mice
Generation of the global Reck-deficient mice and the
histological analyses of the E10.5 embryos and yolk sacs
have been described elsewhere [15]. Mice carrying a
modified Reck allele, named Reck
fl (R2) (Acc. No.
CDB0488K: http://www.cdb.riken.jp/arg/mutant%20mice
%20list.html), in which the 2nd exon was flanked by two
loxP sites, were generated using the bacterial artificial
chromosome (BAC) clone containing the C57BL/6 geno-
mic Reck sequence (RP23-9F18; BACPAC Resources,
Oakland, USA) as a template and following our estab-
lished protocols for constructing targeting vectors (see
http://www.cdb.riken.go.jp/arg/download_file/vector_09).
In brief, the 3.4 kb 5’-arm, 7.9 kb 3’-arm, and 0.4 kb
exon 2-containing fragment of Reck were inserted
respectively into the 5’-, 3’-, and the central cloning sites
of the DT-A/Conditional FW vector http://www.cdb.
riken.go.jp/arg/cassette.html (Additional file 7). Mutant
ES clones were isolated after electroporation of this vec-
tor into TT2 ES cells [42], and a transgenic mouse line
was established using one such clone (No. 25). The
PGK-neo fragment was then eliminated by crossing this
line with a mouse carrying the Flp transgene. The
CreER transgenic mouse [STOCK Tg(CAG-cre/Esr1)
5Amc/J] was obtained from The Jackson Laboratory
(Bar Habor, USA). Reck
fl/fl females were mated with
CAG-CreER;Reck
fl/- males, and tamoxifen (60 mg/kg)
was injected intra-peritoneally into pregnant mice five
times (24 hr interval between each injection) from 11
dpc. Mice carrying the CAG-CreER transgene were not
found among the pups born after this treatment. The
status of the Reck allele was assessed by PCR [primers:
AGTACATGACTTAGGAACAG, AACTGCAA-
TATCTGGGATAC; conditions: 94°C, 30 s/61°C, 30 s/
72°C, 60, 35 cycles; products: 853 bp (wt), 1252 bp (fl),
721 bp (Δ).
Immunoblot assay
Proteins were solubilized and subjected to immunoblot
assay using the anti-RECK antibody 5B11D12 as
described previously [16,22]. The blot was re-probed
using antibodies against the loading control, a-tubulin
(Calbiochem).
Statistical analyses
To count the numbers of Reck-positive capillaries, bifur-
cation points, and terminal cell clusters in the DB, a
total of seven implantation chambers were randomly
selected from 3 pregnant mice at each stage (i.e., 6, 7,
and 8 dpc). Five longitudinal sections (4 μm-thick) near
the central plane of each implantation chamber were
prepared from each chamber. The number of structures
found in five sections from each implantation chamber
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cases of gelatin beads treatment, all the implantation
chambers from 7 mice per group were analyzed. The
statistical significance of difference was assessed by
Student’s t-test.
Additional material
Additional file 1: Reck-immunoreactivity in the inter-implantation
areas of the uteri in pregnant mice. (A) Schematic representation of a
medial longitudinal section of mouse implantation chambers at 7 dpc.
Relative position of the area focused in this figure is highlighted in blue.
(B) Reck-positive uterine epithelium at 7 dpc. A magnified view of the
area as indicated by the blue arrow in panel 1 is shown in panel 2. A
pair of adjacent slices were stained for Reck (panel 3) and Ki67 (panel 4).
The Reck-positive epithelium at this stage is largely non-proliferative
(panels 3, 4, red arrow). (C) Reck-positive cells at 1 dpc. A magnified view
of the area indicated by the blue box in panel 1 is shown in panel 2. A
pair of adjacent slices were stained for Reck (panel 3) and Ki67 (panel 4).
Reck-signals are largely associated with interstitial capillaries but not with
the proliferative uterine epithelium at this stage (panels 3, 4, red arrow).
Scale Bar: B1, B5, 100 μm; B2, 10 μm; B3 & 4, 30 μm; B6, 20 μm; B7 & 8,
50 μm.
Additional file 2: Reck-signals associated with strings of cells in the
AS. (A) Schematic representation of a medial longitudinal section of
mouse implantation chambers at 7 dpc. Relative position of the area
focused here is highlighted in blue. (B) Typical medial (panel 1; e,
embryo) and lateral (panel 2) sections of a 7-dpc implantation chamber
stained for Reck. Reck-signals are abundant in medial sections but not in
lateral sections. In medial sections, the most prominent Reck-signals are
found in the region near DB (red bracket; see Figure 1). In addition,
moderately strong Reck-signals are found in two regions located
symmetrically in the AS (green arrows). In these regions, the Reck-
positive cells form several strings. (C) Pairs of adjacent slices stained for
Reck and SMA (panels 1, 2) or Reck and PECAM (panels 3, 4). Reck-signals
tend to colocalize with SMA-signals (panels 1, 2) rather than PECAM-
signals (panels 3, 4). (D) Fluorescent triple staining for Reck (green),
PECAM (red), and nuclei (blue). The PECAM-positive parts of the strings
(see panel C4, yellow bracket) are also mildly Reck-positive. (E) Adjacent
slices stained for Reck and Ki67. The Reck-positive strings of cells (panel
1) are largely non-proliferative (panel 2). Scale Bar: B, 300 μm; C1 & 2, 50
μm; C3 & 4, 100 μm; D, 20 μm; E, 10 μm.
Additional file 3: Reck-immunoreactivity in the AS at later stages
and in the primary desidual zone (PDZ). (A) Schematic representation
of mouse implantation chambers at 7 dpc. Relative positions of the areas
focused in this figure are highlighted in blue. (B) Reck-immunoreactivity
in the AS at 8 dpc. Magnified view of an area as indicated by yellow
ellipse in panel 1 is shown in panel 2. The expanding sinuses are lined
by Reck-positive cells. Red bracket indicates the area where larger sinuses
are formed and green arrow decidua basalis (DB) where numerous Reck-
positive vessels are found (see Figure 1). (C) Fluorescent triple staining of
a 8.5-dpc slice for Reck (green), PECAM (red), and nuclei (blue). At this
stage, Reck-positive cells show clear endothelial phenotype. (D) The AS
at 9 and 10 dpc stained for Reck. Reck signals become weaker at 9 dpc
(panel 1) and barely detectable at 10 dpc (panel 2). Red arrow indicates
the placental bed. (E) Reck signals associated with decidual cells in the
PDZ at late 7 dpc. Magnified view of the area indicated in the yellow
circle in panel 1 is shown in panel 2. Blue arrow indicates the
trophoblast cell layer. Red arrows indicate clusters of the Reck-positive
decidual cells. Scale Bar: B1, 300 μm; B2, 50 μm; C, 25 μm; D1, 30 μm; D2,
300 μm; E1, 400 μm; E2, 50 μm.
Additional file 4: Reck-positive solitary cells in the DB.( A )A
magnified view of Reck-positive solitary cells in the DB. (B) DB vessels
doubly immuno-stained for Reck and PECAM and observed with a
confocal microscope. (C) Proportion of PECAM-positive or SMA-positive
cells among the Reck-positive solitary cells in the DB (n = 7). Scale bar: A
20 μm ;B5 0μm.
Additional file 5: Examples of Reck-positive vessels in the DB. Serial
sections of 7-dpc implantation chambers were stained with anti-Reck
antibody. (A) The vessel indicated by red arrows shows a bifurcation
(panels 1, 2) and contact zone (panels 3, 4) on the one side, while the
vessel indicated by blue arrows shows bifurcations (panels 1, 2, 6, 7) and
contact zones (panels 3, 5) on both sides along the longitudinal axis. A
possible topology of the latter vessel is shown in panel 8 (not in scale).
(B) The vasculature marked with blue arrows shows a contact zone only
in the central region (panels 2, 3) and not on both sides (panels 1, 4-6)
along the longitudinal axis. A possible topology of the vessel is shown in
panel 7 (not in scale). Scale bar: 50 μm.
Additional file 6: Reck- and type IV collagen-immunoreactivity
around blood vessels in the DB. DB vessels in two adjacent sections
were stained for Reck (A, B) and type IV collagen (C, D). Magnified views
of the area indicated by yellow boxes in (A) and (C) are shown in (B) and
(D), respectively. Type IV collagen is abundant around the Reck-positive
cells. Scale bar: A, C 100 μm; B, D 20 μm.
Additional file 7: Reck targeting strategy. See Methods for detail. PCR
with primers AGTACATGACTTAGGAACAG (®) and
AACTGCAATATCTGGGATAC (¬) generates 853, 1252, and 721-bp
products representing wt, fl,a n dΔ allele, respectively.
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